Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: April 20, 2011
Reporting Period: First Quarter 2011
This filing announces the results of operations for the first quarter of 2011. The detailed financial data is contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 (Press Release).
The company utilizes non-GAAP financial measures to adjust for unusual or unpredictable factors, including:
- Acquisition-related costs
- Currency devaluations
- Legislative reforms
- Litigation reserves
- Acquired in-process research and development
- Restructuring and cost reduction initiatives
- Effects of changes in the calendar year-end for international operations
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. Investors must refer to the incorporated press release (Exhibit 99.1) for comparative performance data.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures provide useful information for evaluating ongoing business performance and are used internally to monitor business performance. However, the company cautions that these measures should be considered in addition to, and not as a substitute for, GAAP financial measures.
Risks and Contingencies: The filing highlights the impact of currency devaluations, legislative reforms, and litigation reserves as factors affecting financial results.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2011 revenue, net earnings, and diluted earnings per share figures.
- Compare GAAP results against non-GAAP adjusted results to understand the impact of one-time items.
- Verify the specific impact of currency devaluations and legislative reforms on the quarter's performance.
- Check for any updated forward-looking guidance provided in the press release.